Skip to main content

Phase I–III Study Design & Execution

Full support for early-phase trials, pivotal studies, and bioequivalence assessments with rich PK/PD integration.

Dose Selection & Adaptive Trial Design

Data-driven approaches to optimize dosing and incorporate adaptive strategies based on interim analyses.

Statistical Analysis & Data Interpretation

Integration of PK/PD modeling, safety, and efficacy endpoints to inform go/no-go decisions and next steps.

Special Population Study Design

Tailored designs for rare diseases, pediatrics, geriatrics, and patients with hepatic or renal impairment.

Regulatory & Strategic Support

Guidance on IND, NDA, and BLA submissions, meeting preparation, and model-informed drug development (MIDD) strategies.

Schedule a Consultation